Breaking News

Optimapharm Acquires Czech-based MKS Research

CRO plans to double its revenues to become the largest independent CRO in Central and Eastern Europe.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Following the global trend of consolidating market positions of clinical research organizations (CROs), Optimapharm, a leading CRO in Southeastern Europe, acquired the Czech-based CRO MKS Research. By acquiring MKS Research, Optimapharm will enter the Czech market, and further strengthen its portfolio of clients in the pharmaceutical and biotech industries and its market position in Central Europe. The company says the acquisition is in line with its medium-term strategic objective of becomin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters